Stockreport

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates

Galera Therapeutics, Inc.  (GRTX) 
PDF MALVERN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, propr [Read more]